Pfizer
Latest statistics and disclosures from Pfizer's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ORIC, ARVN, CELC, WVE, ALLO, and represent 76.92% of Pfizer's stock portfolio.
- Reduced shares in these 4 stocks: BNTX (-$164M), TRML (-$61M), EPIX, Senseonics Hldgs.
- Sold out of its positions in BNTX, EPIX, TRML.
- Pfizer was a net seller of stock by $-225M.
- Pfizer has $237M in assets under management (AUM), dropping by -45.94%.
- Central Index Key (CIK): 0000078003
Tip: Access up to 7 years of quarterly data
Positions held by Pfizer consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Pfizer
Pfizer holds 18 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Oric Pharmaceuticals (ORIC) | 18.6 | $44M | 5.4M | 8.18 |
|
|
| Arvinas Ord (ARVN) | 17.3 | $41M | 3.5M | 11.86 |
|
|
| Celcuity (CELC) | 14.7 | $35M | 349k | 99.74 |
|
|
| Wave Life Sciences SHS (WVE) | 13.5 | $32M | 1.9M | 17.00 |
|
|
| Allogene Therapeutics (ALLO) | 12.8 | $30M | 22M | 1.37 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 6.6 | $16M | 3.0M | 5.24 |
|
|
| Pyxis Oncology Common Stock (PYXS) | 3.4 | $8.1M | 7.0M | 1.15 |
|
|
| Caribou Biosciences (CRBU) | 3.2 | $7.5M | 4.7M | 1.59 |
|
|
| Cardiff Oncology (CRDF) | 2.9 | $6.8M | 2.4M | 2.81 |
|
|
| Biohaven (BHVN) | 2.4 | $5.7M | 506k | 11.29 |
|
|
| Spero Therapeutics (SPRO) | 2.3 | $5.5M | 2.4M | 2.33 |
|
|
| Nextcure Com New (NXTC) | 0.9 | $2.2M | 158k | 14.19 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 0.5 | $1.3M | 954k | 1.35 |
|
|
| Q32 Bio (QTTB) | 0.4 | $922k | 278k | 3.32 |
|
|
| An2 Therapeutics (ANTX) | 0.3 | $815k | 715k | 1.14 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.1 | $171k | 31k | 5.47 |
|
|
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $24k | 2.9k | 8.31 |
|
|
| Senseonics Hldgs | 0.0 | $12k | -95% | 2.2k | 5.52 |
|
Past Filings by Pfizer
SEC 13F filings are viewable for Pfizer going back to 2025
- Pfizer 2025 Q4 filed Feb. 12, 2026
- Pfizer 2025 Q3 filed Nov. 13, 2025
- Pfizer 2025 Q2 filed Aug. 11, 2025
- Pfizer 2025 Q1 filed May 13, 2025